Evidence map›Paper›PMID 30324147›Full record

ArticleClinical and experimental hepatology2018

A good response to steroid therapy in IgG4-related sclerosing cholangitis: a case report.

Jingqiao Zhang, Xiaozhong Guo, Hongyu Li, Xiaodong Shao, Jiao Deng, Zhendong Liang, Xia Zhang, Ji Feng, Hao Lin, Xingshun Qi

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jingqiao ZhangDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Xiaozhong GuoDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Hongyu LiDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Xiaodong ShaoDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Jiao DengDepartment of Pharmacology, General Hospital of Shenyang Military Area, Shenyang, China.
Zhendong LiangDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Xia ZhangNo. 4 People Hospital of Shenyang City, Shenyang, China.
Ji FengDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Hao LinDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
Xingshun QiDepartment of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China.
General Hospital of Shenyang Military Region · CNShenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related sclerosing cholangitis is a rare autoimmune liver disease. Biliary tract imaging, serum IgG4 concentration, and histopathological examination are the major diagnostic criteria for IgG4-related sclerosing cholangitis. In this paper, we report a male patient with yellowish skin, in whom classical liver-protection drugs were initially given, but the efficacy was poor. After that, IgG4-related sclerosing cholangitis was diagnosed, and he achieved a good response to steroid therapy.

Indexed as

cholangitisIgG4liverrelapsesteroid

Identifiers

PMID30324147
PMCPMC6185927
OpenAlexW2896388456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.